Sign in Register

Indication

Desensitization to allergen

Desensitization to allergen refers to an immunologic therapeutic objective or clinical intervention indicated for patients with documented hypersensitivity to specific environmental, dietary, venom, or pharmacologic antigens. Read more about Desensitization to allergen

6 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Desensitization to allergen therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Desensitization to allergen preselected.

News & literature

Coming soon

Related codes

Coming soon

Related conditions & guidelines

Coming soon

About Desensitization to allergen.

Desensitization to allergen refers to an immunologic therapeutic objective or clinical intervention indicated for patients with documented hypersensitivity to specific environmental, dietary, venom, or pharmacologic antigens.

In the context of drug labeling and coding systems, it denotes the management of type I, IgE-mediated or non-IgE-mediated hyperreactivity affecting the immune, respiratory, cutaneous, or systemic cardiovascular systems.

Pathophysiologically, these conditions are characterized by abnormal mast cell and basophil activation that triggers mediator release, manifesting as allergic rhinitis, asthma, urticaria, or life-threatening anaphylaxis.

The clinical state involves inducing temporary or long-term immune tolerance to prevent acute hypersensitivity upon subsequent exposure.

Personalize your experience

Follow Desensitization to allergen and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it